Nanosys

Nanosys is an industry-leading nanotechnology company developing products based on a technology platform incorporating high performance inorganic nanostructures. Our technology is currently being applied to address opportunities in multiple industries, including energy, defense, electronics, computing, and life science. Some current application areas of our technology include flexible electronics, lightweight and conformal solar cells, memory, and novel nanostructured surface coatings.

Progenics Pharmaceuticals

Progenics is a biopharmaceutical company focusing on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Their principal programs are directed toward symptom management and supportive care, human immunodeficiency virus, or HIV, infection, and cancer. The company has four product candidates in clinical development and several others in preclinical development.

Reata Pharmaceuticals

Reata is a biopharmaceutical company formed to discover, develop, and commercialize new drugs that target major unmet clinical needs in cancer, inflammation, and neurodegenerative disease. Reata combines innovative clinical and preclinical candidates, novel drug discovery platforms, and renowned scientists from leading research institutions.

Schneider Vineyards

Schneider Vineyards is a leading ultra-premium winery in the United States with vineyards located on the North Fork of Long Island in New York.

Sentigen

Sentigen Biosciences, a wholly owned operating subsidiary of Sentigen Holding, has developed a proprietary drug discovery platform that has the potential to change the paradigm of modern-day pharmaceutical discovery and development. The company was acquired by Invitrogen for $26 million in September 2006.

Surfparks

Surfparks is a US-based company focused on developing and operating innovative wave-riding facilities. On a mission to deliver every surfer's dream of perfect, uncrowded waves, Surfparks has licensed exclusive rights to proprietary technology capable of delivering world-class surf in controlled, saltwater pools.

Renovis

Renovis was a science-driven, biopharmaceutical company that sought to discover, develop, and commercialize therapeutics for major medical needs in the areas of neurological and inflammatory diseases. The company went public at the NASDAQ for $66 million in February 2004.

Acceptys

Acceptys is a private biotechnology company focused on the development of human antibody therapies in cancer and infectious diseases. The company's key strength is its ability to directly leverage the power of the human immune system, which has continually evolved with the specific purpose of preserving health. Patrys Limited acquired Acceptys in the Fall of 2008.

Angioblast

The company seeks to enhance and extend human life by developing cell therapeutic approaches that treat heart and blood vessel disease. The company is developing novel and proprietary stem cell technology to induce growth of new blood vessels with application in major cardiovascular and circulatory diseases.

RubberWorks International

RubberWorks International is an environmental technology company with a mission to commercialize new size-reduction and waste-processing technologies in the scrap tire and rubber recycling industries.

Nephros

Nephros was founded in 1997 by Columbia University health professionals, scientists, and engineers to improve the quality of life for the end stage renal disease patient, while addressing the critical needs of the care provider. The company went public at the AMEX for $12.6 million in September 2005.

RemoteReality

RemoteReality is the designer and manufacturer of next-generation intelligent omni video systems (IOVS). By integrating high-resolution 360-degree mirrors, optics, sensors, and intelligent processing into single-lens, solid-state, high-frame-rate video appliances, RemoteReality's systems promise 360-degree, real-time, continuous video with the ability to simultaneously detect and track multiple objects, in both visible and infrared thermal spectra.

CallStreet

CallStreet is the leading provider of corrected and formatted transcripts of management conference calls to the investment community. Hundreds of leading firms rely on CallStreet for the most accurate, highest quality content available. The company was acquired by FactSet for $7 million in May 2004.

Skinetics

Based on technology from Dr. Angela Christiano's lab in Dermatology, Skinetics focuses on hair loss and growth. The company was acquired by Sirna for $2 million in December 2004, and was subsequently acquired by Merck.

Time Medical Inc.

Time Medical Inc. is a New Innovation Technology company guided by a singular mission – Developing New Medical Technology for the Good of Humanity.

TiMed was founded by an international team trained at Columbia University, Harvard Medical School and the University of Hong Kong. With industry leadership in Advanced Micro-Electronics and Bio-Medical Engineering, the company produces ground-breaking innovations and cutting-edge MRI solutions for global markets.

The company provides a diversity of software, systems, services, and components for MRI manufacturers, healthcare industry and research institutions. The patented HTS coil technology retrofits current low-field MRI systems into high-field MRI, and empowers the performance of high-field MRI into an high-field MRI. TiMed products enable today's MRI systems to provide robust performance, made portable and affordable with patient-friendly configurations, and safer with the highest imaging resolution.

TiMed is also the world leader in Advanced Medical Device and System Manufacturing for high resolution superconducting coils as well as head-only 3T MRI system. The business strategy of the company is to focus on high quality clinical diagnostic imaging and become a global supplier of healthcare innovations and systems.

SGX Pharmaceuticals

SGX Pharmaceuticals is focused on the discovery, development, and commercialization of innovative cancer therapeutics. Its mission is to provide patients with life-changing therapies through the dedication, innovation, and excellence of its employees. The company went public at the NASDAQ for $24 million in February 2006 and was subsequently bought by Ely Lilly & Co. in 2008.

Schrödinger

Schrödinger is a technology leader in computational chemistry software. Schrödinger provides accurate, reliable, and high performance computational technology to solve real-world problems in pharmaceutical, biotechnology, and materials science research.

Edit.com

Company provides an easy-to-use, cost-effective, and time-saving Web site maintenance service.

Enterprise Air

Enterprise Air is a leading provider of mobile solutions for the physical security and emergency first-responder segments of the homeland security market. The company delivers an integrated suite of mobile software applications that addresses the security and crisis management needs of roaming guards, law enforcement officers, and emergency response workers, using secure handheld devices.

Escoublac, Inc.

Escoublac was founded based on the discovery that osteocalcin, a protein found mostly in bone and dentin, that plays a role in energy metabolism and related disorders. The research findings showed that osteocalcin encouraged weight loss, increased the production of insulin-generating beta cells as well as insulin, and improved sensitivity to insulin. The company aims to transform this discovery into new therapies for metabolic disorders and related conditions, such as type 2 diabetes and obesity. Escoublac is one of the first occupants in Biogen Idec's new Innovation Incubator and has closed a Series A financing.

HX Diagnostics, Inc.

HX Diagnostics, Inc. is a San Francisco Bay Area diagnostics company with a mission to be a global leader in rapid diagnostics for seasonal and emerging infectious diseases. The company is focused on the development and commercialization of seasonal and pandemic influenza assays that will allow clinicians to make rapid assessments of their patient’s health status. HX Diagnostics has relationships with leading avian flu researchers across the globe. The company and its global collaborators share a common focus to bring the first highly effective differentiated point-of-care diagnostic product to simultaneously detect multiple strains of influenza.

Parseon, Inc.

Parseon provides fully automated, real-time knowledge acquisition as part of the first real NLP solution that can enable researchers to navigate and benefit from the over 1,500 articles published each day in the biomedical field. Data are generated using the next generation of information extraction software and will replace today’s keyword systems that merely retrieve lists of articles which then must be read and comprehended manually. Parseon’s OnSolver ServiceTM automates the extraction of knowledge from technical literature, revolutionizing the way researchers in biopharmaceutical and allied scientific industries access information. Its products rapidly mine the escalating flood of scientific text, revealing critical knowledge as a function of key relationships, not merely key words. The system’s unprecedented 95% accuracy and 63% recall approximates human curation but in a small fraction of the time. This means that 95% of the responses returned in response to a query are relevant.

RSoft

The definitive source in design software and services for the telecommunications, optoelectronic, and semiconductor industries, RSoft Design Group develops and markets a family of tools that address design challenges in photonics from active and passive component simulation to optical network design and optical network modeling.

Starion Instruments

Starion Instruments is a California-based startup company that develops surgical instruments. All Starion systems use thermal welding technology to fuse vessels and tissue structures closed in order to stop bleeding.

Memory Pharmaceuticals

Memory Pharmaceuticals, a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating central nervous system disorders, many of which exhibit significant impairment of memory and other cognitive function. The company went public at the NASDAQ for $35 million on April 2004 and was acquired by Roche in 2008.

Redflower

Redflower provides innovative products and concept designs to major museums and nonprofit art organizations.

Cierra

Cierra is a medical device company focused on minimally invasive treatment of heart conditions. The company's PFxTM Closure System is currently undergoing clinical evaluation in Europe for Closure of Patent Foramen Ovale (PFO).

Smart Biosciences

SMART Biosciences is engaged in a coordinated effort to discover and develop novel small-molecule therapeutics to treat major age-related illnesses, including Alzheimer's disease and various forms of cancer. Since its beginning in 2005, SMART has been working to address significant unmet therapeutic needs in these large and rapidly growing markets.

MPEG LA

MPEG LA is a patent licensing partnership for the MPEG-2 international digital compression standard. The patent holders include Columbia University, France Telecom, Fujitsu, General Instrument, JVC, KDD Panasonic (Matsushita Electric), Mitsubishi Electric, NTT, Philips, Samsung, Scientific Atlanta, Sony, and Toshiba.

SIMtone

SIMtone Corporation transforms computing into low cost, network provisionable services, pervasively accessible by everyone. SIMtone Corporation has developed and commercialized the patent-pending SIMtone, a Simple, DialTone-like network service that can deliver on-demand services such as virtual desktop environments, applications, and media content seamlessly to a wide variety of devices including PCs, thin clients, mobile devices, set-top-boxes, and non-processing devices. Its flagship SIMtone VDU is the first of several services that leverage the SIMtone, providing enterprises and government agencies with an innovative model for personal computing that combines unprecedented security, cost savings, and plug-and-play ease of deployment. From an end-user perspective, the SIMtone VDU provides a full desktop experience that can be seamlessly accessed inside and outside the office. SIMtone Corporation is a privately-held company backed by Kodiak Venture Partners and Motorola Ventures. For more information, please visit: www.SIMtoneVDU.com.

Electro-Optical Sciences

EOS is a medical device company focused on the design and development of a noninvasive, point-of-care instrument to assist in the early diagnosis of melanoma. EOS went public at the NASDAQ for $20 million in October 2005.

Pharmacopeia Drug Discovery

Pharmacopeia is a biopharmaceutical company developing small-molecule therapeutics to meet the needs of large patient populations suffering from significant unmet medical needs. Pharmacopeia's programs leverage the company's immunobiology expertise and are focused on diseases such as rheumatoid arthritis, multiple sclerosis, and psoriasis. The company was purchased by Ligand Pharmaceuticals in 2008.

System Management ARTS

System Management ARTS is a leading developer of software to automate management of complex networked systems and identify network problems in real time. The company was acquired by EMC for $260 million in December 2004.